Cullen Buie Parses Pathogens With Passion

Associate Professor, Department of Mechanical Engineering, MIT. Age: 34

Written byAndy Extance
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© DOMINICK REUTER—PHOTOJOURNALISTFrustrated by microbes that refused to grow during a 10-day visit to his Australian collaborators’ lab in 2012, Cullen Buie attended an emergency lunchtime meeting that ended up reshaping his research. The MIT engineer had wanted to use his team’s 3-D microfluidics tool to determine the effectiveness of bacteria for use in microbial fuel cells by analyzing the properties of their surface membranes. But the recalcitrant microbes left him “twiddling his thumbs.” Buie’s University of Queensland collaborators suggested giving him different E. coli strains to analyze. “They said, ‘Maybe you can distinguish pathogens from nonpathogens in your devices,’” Buie recalls. “We saw huge differences in their responses.” That result started his transition from fuel cells to a deeper focus on microbial physiology.

This detour brought Buie closer to his original intention to major in premed as an undergraduate, as his older sister had. But that early plan had changed before he even started college at Ohio State University, when he visited the university’s office of minority affairs, which suggested that an engineering major could either lead to a later medical degree or provide an alternative career. Then, Buie discovered an engineering summer school with college-level classes offering scholarship money to students who did well. “I signed up for the program on Friday, and it started on Sunday,” he says.

Deciding to stick with engineering, Buie did his PhD on microfluidic electro-osmotic pumps for fuel cells with Juan Santiago at Stanford University, finishing in 2009. He then landed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies